Literature DB >> 31632801

A new approach to predicting risk for N2 disease in non-small cell lung cancer.

Roy H Decker1, Justin D Blasberg2.   

Abstract

Entities:  

Year:  2019        PMID： 31632801      PMCID： PMC6783735          DOI： 10.21037/jtd.2019.07.61

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

Review 1.  PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.

Authors:  Mia Schmidt-Hansen; David R Baldwin; Elise Hasler; Javier Zamora; Víctor Abraira; Marta Roqué I Figuls
Journal:  Cochrane Database Syst Rev       Date:  2014-11-13

2.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

3.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica Bauman; Lucian R Chirieac; Thomas A D'Amico; Malcolm M DeCamp; Thomas J Dilling; Michael Dobelbower; Robert C Doebele; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Ritsuko Komaki; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Leah J Leisch; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

Review 4.  Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.

Authors:  Joe Y Chang; Andrea Bezjak; Françoise Mornex
Journal:  J Thorac Oncol       Date:  2015-04       Impact factor: 15.609

5.  Achieving Clarity About Lung Cancer and Opacities.

Authors:  Frank C Detterbeck
Journal:  Chest       Date:  2017-02       Impact factor: 9.410

6.  Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

Authors:  Andrea Bezjak; Rebecca Paulus; Laurie E Gaspar; Robert D Timmerman; William L Straube; William F Ryan; Yolanda I Garces; Anthony T Pu; Anurag K Singh; Gregory M Videtic; Ronald C McGarry; Puneeth Iyengar; Jason R Pantarotto; James J Urbanic; Alexander Y Sun; Megan E Daly; Inga S Grills; Paul Sperduto; Daniel P Normolle; Jeffrey D Bradley; Hak Choy
Journal:  J Clin Oncol       Date:  2019-04-03       Impact factor: 44.544

7.  A Predictive Model for Lymph Node Involvement with Malignancy on PET/CT in Non-Small-Cell Lung Cancer.

Authors:  Malcolm D Mattes; Wolfgang A Weber; Amanda Foster; Ariella B Moshchinsky; Salma Ahsanuddin; Zhigang Zhang; Weiji Shi; Nabil P Rizk; Abraham J Wu; Hani Ashamalla; Andreas Rimner
Journal:  J Thorac Oncol       Date:  2015-08       Impact factor: 15.609

8.  Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Lary A Robinson; John C Ruckdeschel; Henry Wagner; Craig W Stevens
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

9.  Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Gerard A Silvestri; Anne V Gonzalez; Michael A Jantz; Mitchell L Margolis; Michael K Gould; Lynn T Tanoue; Loren J Harris; Frank C Detterbeck
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study.

Authors:  Yusef Moulla; Tanja Gradistanac; Christian Wittekind; Uwe Eichfeld; Ines Gockel; Arne Dietrich
Journal:  J Cardiothorac Surg       Date:  2019-01-16       Impact factor: 1.637
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.